HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Transform Wealth LLC

Transform Wealth LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,278 shares of the company’s stock after buying an additional 2,847 shares during the quarter. Transform Wealth LLC’s holdings in HCA Healthcare were worth $7,587,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth about $39,000. Capital Performance Advisors LLP acquired a new position in HCA Healthcare in the 3rd quarter valued at $41,000. Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare during the second quarter worth about $33,000. Canoe Financial LP acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at approximately $44,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on HCA shares. Morgan Stanley cut their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Barclays cut their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.27.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $310.60 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $278.50 and a 1-year high of $417.14. The company has a market cap of $78.68 billion, a price-to-earnings ratio of 13.95, a price-to-earnings-growth ratio of 1.06 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock’s 50-day moving average is $315.74 and its two-hundred day moving average is $353.08.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.